missing translation for 'onlineSavingsMsg'
Learn More

STT3B Rabbit anti-Human, Mouse, Rat, Polyclonal, Proteintech

Rabbit Polyclonal Antibody

140.00€ - 399.00€

Especificaciones

Antígeno STT3B
Concentración 0.38 mg/mL
Aplicaciones Immunocytochemistry, Immunofluorescence, Western Blot, Immunohistochemistry (Paraffin)
Clasificación Polyclonal
Conjugado Unconjugated
Ver más especificaciones

Productos 2
Código de producto Marca Cantidad Precio Cantidad y disponibilidad  
Código de producto Marca Cantidad Precio Cantidad y disponibilidad  
16874454
Ver documentos Detalles de la promoción
Proteintech
15323-1-AP-20UL
20 μL
140.00€
20 microlitros
Ver productos alternativos
Ahorre hasta 
»
Fecha estimada de envío: 07-08-2024
para ver el stock
Por favor, para comprar este producto. ¿No tiene usuario web? Regístrese hoy mismo.
16864454
Ver documentos Detalles de la promoción
Proteintech
15323-1-AP-150UL
150 μL
399.00€
150 microlitros
Ver productos alternativos
Ahorre hasta 
»
Fecha estimada de envío: 07-08-2024
para ver el stock
Por favor, para comprar este producto. ¿No tiene usuario web? Regístrese hoy mismo.
Descripción

Descripción

Catalytic subunit of the oligosaccharyl transferase (OST) complex that catalyzes the initial transfer of a defined glycan (Glc(3)Man(9)GlcNAc(2) in eukaryotes) from the lipid carrier dolichol-pyrophosphate to an asparagine residue within an Asn-X-Ser/Thr consensus motif in nascent polypeptide chains, the first step in protein N-glycosylation. N-glycosylation occurs cotranslationally and the complex associates with the Sec61 complex at the channel-forming translocon complex that mediates protein translocation across the endoplasmic reticulum (ER). All subunits are required for a maximal enzyme activity. This subunit contains the active site and the acceptor peptide and donor lipid-linked oligosaccharide (LLO) binding pockets (By similarity). STT3B is present in a small subset of OST complexes and mediates both cotranslational and post-translational N-glycosylation of target proteins: STT3B-containing complexes are required for efficient post-translational glycosylation and while they are less competent than STT3A-containing complexes for cotranslational glycosylation, they have the ability to mediate glycosylation of some nascent sites that are not accessible for STT3A. STT3B-containing complexes also act post-translationally and mediate modification of skipped glycosylation sites in unfolded proteins. Plays a role in ER-associated degradation (ERAD) pathway that mediates ubiquitin-dependent degradation of misfolded endoplasmic reticulum proteins by mediating N-glycosylation of unfolded proteins, which are then recognized by the ERAD pathway and targeted for degradation. Mediates glycosylation of the disease variant AMYL-TTR ′Asp-38′ of TTR at ′Asn-118′, leading to its degradation.
Especificaciones

Especificaciones

STT3B
Immunocytochemistry, Immunofluorescence, Western Blot, Immunohistochemistry (Paraffin)
Unconjugated
Rabbit
Rat, Mouse, Human
Q3TDQ1, Q8TCJ2
201595, 363160, 68292
STT3B Fusion Protein Ag2039
Primary
-20°C
STT3B
0.38 mg/mL
Polyclonal
Liquid
RUO
PBS with 50% glycerol and 0.02% sodium azide; pH 7.3
SIMP, STT3 B, STT3B
Stt3b
IgG
Antigen Affinity Chromatography
Antibody
Videos
SDS
Documentos

Documentos

Product Certifications